极性[125I]I-1,2,4,5-四嗪的合成和放射性标记

IF 0.9 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS
Natasha Bidesi, Vladimir Shalgunov, Umberto Maria Battisti, Lars Hvass, Jesper Tranekjær Jørgensen, Christian B. M. Poulie, Andreas I. Jensen, Andreas Kjaer, Matthias M. Herth
{"title":"极性[125I]I-1,2,4,5-四嗪的合成和放射性标记","authors":"Natasha Bidesi,&nbsp;Vladimir Shalgunov,&nbsp;Umberto Maria Battisti,&nbsp;Lars Hvass,&nbsp;Jesper Tranekjær Jørgensen,&nbsp;Christian B. M. Poulie,&nbsp;Andreas I. Jensen,&nbsp;Andreas Kjaer,&nbsp;Matthias M. Herth","doi":"10.1002/jlcr.4009","DOIUrl":null,"url":null,"abstract":"<p>Pretargeting imaging has gained a lot of prominence, due to its excellent bioorthogonality and improved imaging contrast compared to conventional imaging. A new iodo tetrazine (Tz) derivative has been synthesized and further developed into the corresponding iodine-125 (<sup>125</sup>I) analog (<b>12</b>), via the trimethylstannane precursor. Radiolabeling with either <i>N</i>-chlorosuccinimide or chloramine-T, in either MeCN or MeOH proceeded with a radiochemical conversion (RCC) of &gt;80%. Subsequent deprotection only proved successful, among the tested conditions, when the radiolabeled Tz was stirred in 6-M HCl<sub>(aq.)</sub> at 60°C for 2.5 h. To the best of our knowledge, this is the first H-tetrazine labeled with iodine. In vivo investigations on the pretargeting ability of <b>12</b> are currently under way.</p>","PeriodicalId":16288,"journal":{"name":"Journal of labelled compounds & radiopharmaceuticals","volume":"66 1","pages":"22-30"},"PeriodicalIF":0.9000,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jlcr.4009","citationCount":"1","resultStr":"{\"title\":\"Synthesis and radiolabeling of a polar [125I]I-1,2,4,5-tetrazine\",\"authors\":\"Natasha Bidesi,&nbsp;Vladimir Shalgunov,&nbsp;Umberto Maria Battisti,&nbsp;Lars Hvass,&nbsp;Jesper Tranekjær Jørgensen,&nbsp;Christian B. M. Poulie,&nbsp;Andreas I. Jensen,&nbsp;Andreas Kjaer,&nbsp;Matthias M. Herth\",\"doi\":\"10.1002/jlcr.4009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Pretargeting imaging has gained a lot of prominence, due to its excellent bioorthogonality and improved imaging contrast compared to conventional imaging. A new iodo tetrazine (Tz) derivative has been synthesized and further developed into the corresponding iodine-125 (<sup>125</sup>I) analog (<b>12</b>), via the trimethylstannane precursor. Radiolabeling with either <i>N</i>-chlorosuccinimide or chloramine-T, in either MeCN or MeOH proceeded with a radiochemical conversion (RCC) of &gt;80%. Subsequent deprotection only proved successful, among the tested conditions, when the radiolabeled Tz was stirred in 6-M HCl<sub>(aq.)</sub> at 60°C for 2.5 h. To the best of our knowledge, this is the first H-tetrazine labeled with iodine. In vivo investigations on the pretargeting ability of <b>12</b> are currently under way.</p>\",\"PeriodicalId\":16288,\"journal\":{\"name\":\"Journal of labelled compounds & radiopharmaceuticals\",\"volume\":\"66 1\",\"pages\":\"22-30\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2022-12-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jlcr.4009\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of labelled compounds & radiopharmaceuticals\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jlcr.4009\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOCHEMICAL RESEARCH METHODS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of labelled compounds & radiopharmaceuticals","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jlcr.4009","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 1

摘要

与传统成像相比,预靶成像由于其优异的生物正交性和提高的成像对比度而备受关注。合成了一种新的碘四嗪(Tz)衍生物,并通过三甲基锡前体进一步发展为相应的碘-125(125I)类似物(12)。用N-氯琥珀酰亚胺或氯胺-T在MeCN或MeOH中的放射标记进行>;80%。在测试条件中,当放射性标记的Tz在6-M HCl(水溶液)中在60°C下搅拌2.5小时时,随后的脱保护才被证明是成功的。据我们所知,这是第一个用碘标记的h-四嗪。目前正在对12的预靶向能力进行体内研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Synthesis and radiolabeling of a polar [125I]I-1,2,4,5-tetrazine

Synthesis and radiolabeling of a polar [125I]I-1,2,4,5-tetrazine

Pretargeting imaging has gained a lot of prominence, due to its excellent bioorthogonality and improved imaging contrast compared to conventional imaging. A new iodo tetrazine (Tz) derivative has been synthesized and further developed into the corresponding iodine-125 (125I) analog (12), via the trimethylstannane precursor. Radiolabeling with either N-chlorosuccinimide or chloramine-T, in either MeCN or MeOH proceeded with a radiochemical conversion (RCC) of >80%. Subsequent deprotection only proved successful, among the tested conditions, when the radiolabeled Tz was stirred in 6-M HCl(aq.) at 60°C for 2.5 h. To the best of our knowledge, this is the first H-tetrazine labeled with iodine. In vivo investigations on the pretargeting ability of 12 are currently under way.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.30
自引率
0.00%
发文量
57
审稿时长
1 months
期刊介绍: The Journal of Labelled Compounds and Radiopharmaceuticals publishes all aspects of research dealing with labeled compound preparation and applications of these compounds. This includes tracer methods used in medical, pharmacological, biological, biochemical and chemical research in vitro and in vivo. The Journal of Labelled Compounds and Radiopharmaceuticals devotes particular attention to biomedical research, diagnostic and therapeutic applications of radiopharmaceuticals, covering all stages of development from basic metabolic research and technological development to preclinical and clinical studies based on physically and chemically well characterized molecular structures, coordination compounds and nano-particles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信